{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T20:47:41Z","timestamp":1768250861247,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T00:00:00Z","timestamp":1472515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ipsen Pharma GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00345-016-1925-0","type":"journal-article","created":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T05:54:38Z","timestamp":1472536478000},"page":"737-744","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III"],"prefix":"10.1007","volume":"35","author":[{"name":"for the OPTIC III Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Bach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"Bastian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Blana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika","family":"Kaminsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Knoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soeren","family":"Promnitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhard","family":"Ubrig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Qvick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,30]]},"reference":[{"key":"1925_CR1","volume-title":"Guidelines on non-muscle-invasive bladder cancer (Ta, T1 and CIS)","author":"M Babjuk","year":"2015","unstructured":"Babjuk M, B\u00f6hle A, Burger E, Comp\u00e9rat E, Kaasinen E, Palou J, Roupr\u00eatt M, van Rhijn BWG, Shariat S, Sylvester R, Zigeuner R (2015) Guidelines on non-muscle-invasive bladder cancer (Ta, T1 and CIS). European Association of Urology, Arnhem"},{"issue":"Suppl 2","key":"1925_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1464-410X.2009.09150.x","volume":"105","author":"C Bunce","year":"2010","unstructured":"Bunce C, Ayres BE, Griffiths TR, Mostafid H, Kelly J, Persad R, Kockelbergh R (2010) The role of hexylaminolaevulinate in the diagnosis and follow-up of non-muscle-invasive bladder cancer. BJU Int 105(Suppl 2):2\u20137. doi:\n                        10.1111\/j.1464-410X.2009.09150.x","journal-title":"BJU Int"},{"issue":"5","key":"1925_CR3","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.eururo.2013.03.059","volume":"64","author":"M Burger","year":"2013","unstructured":"Burger M, Grossman HB, Droller M, Schmidbauer J, Hermann G, Dragoescu O, Ray E, Fradet Y, Karl A, Burgues JP, Witjes JA, Stenzl A, Jichlinski P, Jocham D (2013) Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur Urol 64(5):846\u2013854. doi:\n                        10.1016\/j.eururo.2013.03.059","journal-title":"Eur Urol"},{"issue":"1","key":"1925_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.juro.2012.03.007","volume":"188","author":"HB Grossman","year":"2012","unstructured":"Grossman HB, Stenzl A, Fradet Y, Mynderse LA, Kriegmair M, Witjes JA, Soloway MS, Karl A, Burger M (2012) Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy. J Urol 188(1):58\u201362. doi:\n                        10.1016\/j.juro.2012.03.007","journal-title":"J Urol"},{"issue":"3","key":"1925_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3109\/21681805.2015.1019562","volume":"49","author":"MR Lykke","year":"2015","unstructured":"Lykke MR, Nielsen TK, Ebbensgaard NA, Zieger K (2015) Reducing recurrence in non-muscle-invasive bladder cancer using photodynamic diagnosis and immediate post-transurethral resection of the bladder chemoprophylaxis. Scand J Urol 49(3):230\u2013236. doi:\n                        10.3109\/21681805.2015.1019562","journal-title":"Scand J Urol"},{"key":"1925_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/1756287213510590","volume":"6","author":"P Oude Elferink","year":"2014","unstructured":"Oude Elferink P, Witjes J (2014) Blue-light cystoscopy in the evaluation of non-muscle-invasive bladder cancer. Ther Adv Urol 6:25\u201333. doi:\n                        10.1177\/1756287213510590","journal-title":"Ther Adv Urol"},{"issue":"12","key":"1925_CR7","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1007\/s00464-012-2387-0","volume":"26","author":"A Lapini","year":"2012","unstructured":"Lapini A, Minervini A, Masala A, Schips L, Pycha A, Cindolo L, Giannella R, Martini T, Vittori G, Zani D, Bellomo F, Cunico SC (2012) A comparison of hexaminolevulinate (Hexvix\u00ae) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study. Surg Endosc 26(12):3634\u20133641. doi:\n                        10.1007\/s00464-012-2387-0","journal-title":"Surg Endosc"},{"issue":"1","key":"1925_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/bju.13020","volume":"116","author":"J Palou","year":"2014","unstructured":"Palou J, Hernandez C, Solsona E, Abascal R, Burgues J, Rioja C, Cabrera J, Gutierrez C, Rodriguez O, Iborra I, Herranz F, Abascal J, Conde G, Oliva J (2015) Effectiveness of hexaminolevulinate fluorescence cystoscopy for the diagnosis of non-muscle-invasive bladder cancer in daily clinical practice: a Spanish multicentre observational study. BJU Int 116(1):37\u201343. doi:\n                        10.1111\/bju.13020","journal-title":"BJU Int"},{"issue":"4","key":"1925_CR9","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.eururo.2013.07.007","volume":"64","author":"M Rink","year":"2013","unstructured":"Rink M, Babjuk M, Catto JW, Jichlinski P, Shariat SF, Stenzl A, Stepp H, Zaak D, Witjes JA (2013) Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature. Eur Urol 64(4):624\u2013638. doi:\n                        10.1016\/j.eururo.2013.07.007","journal-title":"Eur Urol"},{"issue":"5","key":"1925_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.purol.2015.01.004","volume":"25","author":"M Roupret","year":"2015","unstructured":"Roupret M, Malavaud B, Molinier L, Leleu H, Blachier M, Marteau F (2015) Cost-effectiveness of transurethral resection of the bladder with blue light in patients with non muscle invasive bladder cancer in France. Prog Urol 25(5):256\u2013264. doi:\n                        10.1016\/j.purol.2015.01.004","journal-title":"Prog Urol"},{"issue":"5","key":"1925_CR11","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.juro.2010.06.148","volume":"184","author":"A Stenzl","year":"2010","unstructured":"Stenzl A, Burger M, Fradet Y, Mynderse LA, Soloway MS, Witjes JA, Kriegmair M, Karl A, Shen Y, Grossman HB (2010) Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. J Urol 184(5):1907\u20131913. doi:\n                        10.1016\/j.juro.2010.06.148","journal-title":"J Urol"},{"issue":"13","key":"1925_CR12","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.purol.2013.08.242","volume":"23","author":"D Jacqmin","year":"2013","unstructured":"Jacqmin D, Molinier L, Irani J, Jichlinski P, De la Taille A, Rabbani M, Malavaud B (2013) The contribution of hexylaminol\u00e9vulinate (Hexvix\u00ae) to the treatment of non muscle invasive bladder tumors: results from the HOPE observational study (Hexvix\u00ae Observational Patients Evaluation). Prog Urol 23(13):1123. doi:\n                        10.1016\/j.purol.2013.08.242","journal-title":"Prog Urol"},{"key":"1925_CR13","unstructured":"Commission Delegated Regulation (EU) No 357\/2014 of 3 February 2014 supplementing Directive\n2001\/83\/EC of the European Parliament and of the Council and Regulation (EC) No 726\/2004 of the European\nParliament and of the Council as regards situations in which post-authorisation efficacy studies may be required\nText with EEA relevance (2014) Offi J Eur Union. \n                        http:\/\/eur-lex.europa.eu\/legalcontent\/EN\/TXT\/PDF\/?uri=CELEX:32014R0357&from=EN\n                        \n                    . Accessed 26 Aug 2016"},{"key":"1925_CR14","unstructured":"Hexvix\u00ae Fachinformation-Summary of product characteristics (2016) Ipsen pharma germany. \n                        https:\/\/www.medicines.org.uk\/emc\/medicine\/27028\n                        \n                    . Accessed 26 Aug 2016"},{"issue":"2","key":"1925_CR15","first-page":"6227","volume":"19","author":"JR Mark","year":"2012","unstructured":"Mark JR, Gelpi-Hammerschmidt F, Trabulsi EJ, Gomella LG (2012) Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer. Can J Urol 19(2):6227\u20136231","journal-title":"Can J Urol"},{"issue":"8","key":"1925_CR16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2217\/fon-2015-0021","volume":"12","author":"V Dansk","year":"2016","unstructured":"Dansk V, Malmstrom PU, Blackberg M, Malmenas M (2016) Hexaminolevulinate hydrochloride blue-light flexible cystoscopy in the detection and follow-up of nonmuscle-invasive bladder cancer: cost consequences during outpatient surveillance in Sweden. Future oncol 12(8):1025\u20131038. doi:\n                        10.2217\/fon-2015-0021","journal-title":"Future oncol"},{"issue":"8 Pt 2","key":"1925_CR17","doi-asserted-by":"publisher","first-page":"E297","DOI":"10.1111\/j.1464-410X.2011.10090.x","volume":"108","author":"GG Hermann","year":"2011","unstructured":"Hermann GG, Mogensen K, Carlsson S, Marcussen N, Duun S (2011) Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta\/T1 patients: a randomized two-centre study. BJU Int 108(8 Pt 2):E297\u2013E303. doi:\n                        10.1111\/j.1464-410X.2011.10090.x","journal-title":"BJU Int"},{"issue":"10","key":"1925_CR18","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00345-015-1485-8","volume":"33","author":"G Gakis","year":"2015","unstructured":"Gakis G, Ngamsri T, Rausch S, Mischinger J, Todenhofer T, Schwentner C, Schmid MA, Hassan FA, Renninger M, Stenzl A (2015) Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy. World J Urol 33(10):1429\u20131437. doi:\n                        10.1007\/s00345-015-1485-8","journal-title":"World J Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-016-1925-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-016-1925-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-016-1925-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-016-1925-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T09:28:58Z","timestamp":1492594138000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-016-1925-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,30]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["1925"],"URL":"https:\/\/doi.org\/10.1007\/s00345-016-1925-0","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,30]]}}}